Skip to main content
. 2020 Apr 24;21(8):3021. doi: 10.3390/ijms21083021

Figure 1.

Figure 1

Summary of the overall approach of EDCMET with two parallel, intertwined work streams for the development of novel candidate methods for regulatory use and for the identification of novel adverse outcome pathways (AOPs).